[go: up one dir, main page]

BR9606455A - Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário - Google Patents

Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário

Info

Publication number
BR9606455A
BR9606455A BR9606455A BR9606455A BR9606455A BR 9606455 A BR9606455 A BR 9606455A BR 9606455 A BR9606455 A BR 9606455A BR 9606455 A BR9606455 A BR 9606455A BR 9606455 A BR9606455 A BR 9606455A
Authority
BR
Brazil
Prior art keywords
peptide
pharmaceutical compositions
obtaining process
process pharmaceutical
synthetic peptide
Prior art date
Application number
BR9606455A
Other languages
English (en)
Inventor
Jean-Louis Kraus
Valerie Niddam
Michel Camplo
Original Assignee
Laphal Laboratoires Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laphal Laboratoires Sa filed Critical Laphal Laboratoires Sa
Publication of BR9606455A publication Critical patent/BR9606455A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08RNA viruses
    • C07K14/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16HIV-1 ; HIV-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BR9606455A 1995-06-29 1996-06-28 Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário BR9606455A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507817A FR2736055B1 (fr) 1995-06-29 1995-06-29 Nouveaux thiophenoxy peptides, leur procede de preparation et les compositions pharmaceutiques en renfermant
PCT/FR1996/001008 WO1997001576A2 (fr) 1995-06-29 1996-06-28 Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment

Publications (1)

Publication Number Publication Date
BR9606455A true BR9606455A (pt) 1998-07-14

Family

ID=9480502

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606455A BR9606455A (pt) 1995-06-29 1996-06-28 Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário

Country Status (17)

Country Link
US (1) US5844078A (pt)
EP (1) EP0787143A2 (pt)
JP (1) JPH10505613A (pt)
KR (1) KR970705576A (pt)
CN (1) CN1165521A (pt)
AP (1) AP683A (pt)
AU (1) AU706799B2 (pt)
BR (1) BR9606455A (pt)
CA (1) CA2197861A1 (pt)
FR (1) FR2736055B1 (pt)
HU (1) HUP9701940A3 (pt)
IL (1) IL120341A (pt)
NO (1) NO970895D0 (pt)
NZ (1) NZ312726A (pt)
OA (1) OA10403A (pt)
PL (1) PL318880A1 (pt)
WO (1) WO1997001576A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1292438B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Derivati peptidomimetici inibitori suicidi della proliferazione del hiv
US6118226A (en) 1998-07-31 2000-09-12 Federal-Mogul World Wide, Inc. Electrodeless neon light module for vehicle lighting systems
US8886480B2 (en) 2011-06-27 2014-11-11 Synaptics Incorporated System and method for signaling in gradient sensor devices
US9188675B2 (en) 2012-03-23 2015-11-17 Synaptics Incorporated System and method for sensing multiple input objects with gradient sensor devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1193598A (en) * 1982-05-06 1985-09-17 Rafael Foguet 2-amino-benzoic acid derivatives and processes for their production
US4454065A (en) * 1982-05-18 1984-06-12 Smithkline Beckman Corporation Oligopeptide prodrugs
ZA832844B (en) * 1982-05-18 1984-03-28 Smithkline Beckman Corp Oligopeptide prodrugs
US5036054A (en) * 1988-02-11 1991-07-30 Warner-Lambert Company Renin inhibitors containing alpha-heteroatom amino acids
US5221667A (en) * 1990-01-22 1993-06-22 Warner-Lambert Company Renin inhibiting peptides having an α-heteroatom amino acid at the P3 position

Also Published As

Publication number Publication date
AU6462496A (en) 1997-01-30
OA10403A (fr) 2001-12-05
NZ312726A (en) 1998-07-28
CN1165521A (zh) 1997-11-19
JPH10505613A (ja) 1998-06-02
NO970895L (no) 1997-02-27
HUP9701940A3 (en) 2001-07-30
EP0787143A2 (fr) 1997-08-06
AU706799B2 (en) 1999-06-24
FR2736055A1 (fr) 1997-01-03
WO1997001576A3 (fr) 1997-05-15
FR2736055B1 (fr) 1997-09-12
KR970705576A (ko) 1997-10-09
CA2197861A1 (fr) 1997-01-16
AP683A (en) 1998-09-30
AP9700964A0 (en) 1997-04-30
IL120341A (en) 2001-01-28
IL120341A0 (en) 1997-06-10
HUP9701940A2 (hu) 1998-03-02
WO1997001576A2 (fr) 1997-01-16
US5844078A (en) 1998-12-01
PL318880A1 (en) 1997-07-07
NO970895D0 (no) 1997-02-27

Similar Documents

Publication Publication Date Title
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
BR9607669A (pt) Derivado de hormõnio de peptídeo e processo de proporcionar o mesmo
NO20004345D0 (no) Farmasøytisk sammensetning
BR9406411A (pt) Composição de xampu
IS4706A (is) Lyfjasamsetningar
BR9406028A (pt) Composição e processo de limpeza
BR9606984A (pt) Vassoura e conjunto de vassoura
BR9604906A (pt) Agentes anti-fúngicos de peptídeo cíclico
DE69620642D1 (de) Reiningungsverfahren und-zusammensetzung
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
BR9601133A (pt) Produto de fibra
LV11727A (lv) Farmaceitiska kompozicija
BR9609671A (pt) Amino uracilas substituídas
FI973229L (fi) Uusi farmaseuttinen koostumus
BR9801205A (pt) Processo e produto
BR9603114A (pt) Processo de preparação de talharim
EP0821694A4 (en) CONOTOXIN PEPTIDE
FI973280L (fi) Farmaseuttinen koostumus
BR9606455A (pt) Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
BR9605777A (pt) Composição farmacêutica
FI960423A7 (fi) 4-merkapto-bentsoyyliguanidiinijohdannaiset

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]